What this study is
This study collects information to maintain a database on patients with low-grade ovarian or peritoneal tumors. Collecting information about the type of cancer and treatment, as well as details about follow-up care, may help researchers learn and better understand these tumor types and help develop better treatments for them.
What's being tested
- Biospecimen Collection
Intervention · PROCEDURE
Patients' residual tissue samples are collected
- Electronic Health Record Review
Intervention · OTHER
Medical records are reviewed
Study details
- Official title
- Data Collection for Patients With Low Grade Ovarian Carcinoma
- Sponsor
- M.D. Anderson Cancer Center
- Conditions
- Low Grade Ovarian Serous Adenocarcinoma · Malignant Ovarian Neoplasm · Ovarian Carcinoma · Primary Peritoneal Carcinoma · Primary Peritoneal Low Grade Serous Adenocarcinoma · Psammocarcinoma
- Enrolling
- 2,000 people
- Starts
- 2006-05-19
- Est. completion
- 2035-05-01
- Record
- View on ClinicalTrials.gov ↗
Who can join
Sex FEMALEHealthy volunteers Not acceptedYou may qualify if
- Patients whose disease progressed to a higher-grade carcinoma since the time of original diagnosis:; Ovarian tumor of low malignant potential; Low-grade serous carcinoma of the ovary; Primary peritoneal tumor of low malignant potential; Low-grade serous carcinoma of the peritoneum; Psammocarcinoma
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openM D Anderson Cancer Center
Houston, Texas, United States
- David M. Gershenson · Contact713-563-4535
- David M. Gershenson · Principal investigator
Recruiting
Study team
Sponsor
M.D. Anderson Cancer Center
Study ID 2006-0137
Principal investigator
David M Gershenson
M.D. Anderson Cancer Center
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.